Travere Therapeutics Inc (NASDAQ:TVTX)

19.50
Delayed Data
As of Nov 25
 +0.17 / +0.88%
Today’s Change
18.92
Today|||52-Week Range
31.65
-37.18%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Travere Therapeutics Inc have a median target of 35.50, with a high estimate of 44.00 and a low estimate of 17.00. The median estimate represents a +82.05% increase from the last price of 19.50.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Travere Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.04
Sales
$58.4M
Reporting Date
Feb 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.86%
 
 
 
 
 
 
Growthannually -45.18%
 
 
 
 
 
 

Sales

Growthquarterly 15.05%
 
 
 
 
 
 
Growthannually -6.78%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.